PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release

Bicyclic nitroimidazoles, including PA-824, are exciting candidates for the treatment of tuberculosis. These prodrugs require intracellular activation for their biological function. We found that Rv3547 is a deazaflavin-dependent nitroreductase (Ddn) that converts PA-824 into three primary metabolit...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Singh, Ramandeep, Manjunatha, Ujjini, Boshoff, Helena I. M., Ha, Young Hwan, Niyomrattanakit, Pornwaratt, Ledwidge, Richard, Dowd, Cynthia S., Lee, Ill Young, Kim, Pilho, Zhang, Liang, Kang, Sunhee, Keller, Thomas H., Jiricek, Jan, Barry, Clifton E.
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2723733/
https://ncbi.nlm.nih.gov/pubmed/19039139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/science.1164571
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares